期刊文献+
共找到137篇文章
< 1 2 7 >
每页显示 20 50 100
Protein Expression of BLM Gene and Its Apoptosis Sensitivity in Hematopoietic Tumor Cell Strains 被引量:6
1
作者 王晓蓓 胡丽华 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2008年第1期46-48,共3页
Patients with Bloom syndrome (BS) show an immunodeficiency, an enhanced sister chromatid exchanges (SCEs), a strong genetic instability and an increased predisposition to all. In order to investigate the different... Patients with Bloom syndrome (BS) show an immunodeficiency, an enhanced sister chromatid exchanges (SCEs), a strong genetic instability and an increased predisposition to all. In order to investigate the differential expression of BLM protein in hematopoietic tumor cell strains and study the effects of BLM gene on ultraviolet (UV)- or hydroxyurea (HU)-induced apoptosis, Western blot was used to detect the expression of BLM protein in normal human bone marrow mononuclear cells and 4 kinds of hematopoietic tumor cell strains. The 4 kinds of hematopoietic tumor cells were exposed to UV light with a germicidal UV lamp or treated with 2 mmol/L hydroxyurea and the apoptotic rate was detected by using AnnexinV-FITC. The results showed that these tumor cells expressed BLM protein higher than the normal human bone marrow mononuclear cells (P〈0.01). In the 4 hematopoietic tumor cells, BLM protein was all specially cleaved in response to UV- or HU-induced apoptosis. The increase of BLM protein expression may play an important role in the development of these tumors, and BLM proteolysis is likely to be a general feature of the apoptotic response. 展开更多
关键词 BLM gene protein APOPTOSIS hematopoietic tumor cell strains
下载PDF
Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways 被引量:9
2
作者 Michael J Nemeth David M Bodine 《Cell Research》 SCIE CAS CSCD 2007年第9期746-758,共13页
Hematopoietic stem cells (HSCs) are a rare population of cells that are responsible for life-long generation of blood cells of all lineages. In order to maintain their numbers, HSCs must establish a balance between ... Hematopoietic stem cells (HSCs) are a rare population of cells that are responsible for life-long generation of blood cells of all lineages. In order to maintain their numbers, HSCs must establish a balance between the opposing cell fates of self-renewal (in which the ability to function as HSCs is retained) and initiation of hematopoietic differentiation. Multiple signaling pathways have been implicated in the regulation of HSC cell fate. One such set of pathways are those activated by the Wnt family of ligands. Wnt signaling pathways play a crucial role during embryogenesis and deregulation of these pathways has been implicated in the formation of solid tumors. Wnt signaling also plays a role in the regulation of stem cells from multiple tissues, such as embryonic, epidermal, and intestinal stem cells. However, the function of Wnt signaling in HSC biology is still controversial. In this review, we will discuss the basic characteristics of the adult HSC and its regulatory microenvironment, the "niche", focusing on the regulation of the HSC and its niche by the Wnt signaling pathways. 展开更多
关键词 HEMATOPOIESIS hematopoietic stem cell Wnt proteins OSTEOBLAST
下载PDF
异基因造血干细胞移植输血不良反应风险预警模型的构建及验证
3
作者 张燕 季玲 顾伟英 《护理研究》 北大核心 2024年第14期2484-2489,共6页
目的:探讨异基因造血干细胞移植(allo-HSCT)输血不良反应的危险因素,建立风险预警模型。方法:选取2018年1月—2023年2月我院收治的115例allo-HSCT病人作为研究对象,将其分为建模组(73例)和验证组(42例)。对病人一般资料进行调查,对病人... 目的:探讨异基因造血干细胞移植(allo-HSCT)输血不良反应的危险因素,建立风险预警模型。方法:选取2018年1月—2023年2月我院收治的115例allo-HSCT病人作为研究对象,将其分为建模组(73例)和验证组(42例)。对病人一般资料进行调查,对病人血清中C反应蛋白(CRP)、白蛋白(ALB)、中性粒细胞、淋巴细胞进行检验,计算CRP/ALB和中性粒细胞与淋巴细胞比值(NLR),采用单因素分析和Logistic回归分析筛选allo-HSCT输血不良反应的危险因素,构建风险预警模型并转化为风险评分系统;采用受试者工作特征(ROC)曲线和Hosmer-Lemeshow(H-L)检验评价模型的区分度与校准度;对预警模型进行验证。结果:发生输血不良反应组CRP/ALB和NLR高于未发生输血不良反应组,差异有统计学意义(均P<0.05)。Logistic回归分析结果显示,输血次数≥3次、有原发性血液病史、有输血史、有过敏史、病人基础体温≥38℃、发血至输血时间≥30 min、输注红细胞滴速每分钟≥50滴、输注血小板滴速每分钟≥90滴以及CRP/ALB≥0.90和NLR≥1.37是allo-HSCT发生输血不良反应的危险因素(均P<0.05)。建模组ROC曲线下面积为0.841,H-L检验结果显示P=0.856,模型的灵敏度为0.909,特异度为0.775,Youden指数为0.684。验证组ROC曲线下面积为0.798,H-L检验结果显示P=0.813,灵敏度为0.818,特异度为0.775,Youden指数为0.593。结论:构建的allo-HSCT输血不良反应风险预警模型预测效能较好,可为allo-HSCT输血不良反应的护理提供针对性的指导。 展开更多
关键词 异基因造血干细胞移植(allo-HSCT) C反应蛋白/白蛋白(CRP/ALB) 中性粒细胞/淋巴细胞比值(NLR) 输血 不良反应 预警模型 护理
下载PDF
造血干细胞标志分子CD34的结构与功能新认识
4
作者 罗军涛 卢莹 《中国医学前沿杂志(电子版)》 CSCD 北大核心 2024年第9期16-19,I0002,共5页
CD34是造血干/祖细胞最主要的膜表面标志物,是临床上造血干细胞移植(hematopoietic stem cell transplanta-tion,HSCT)中评估和选择供体移植物的核心指标。然而,令人惊讶的是,CD34的生物学功能至今仍然知之甚少。尽管已有研究揭示了CD3... CD34是造血干/祖细胞最主要的膜表面标志物,是临床上造血干细胞移植(hematopoietic stem cell transplanta-tion,HSCT)中评估和选择供体移植物的核心指标。然而,令人惊讶的是,CD34的生物学功能至今仍然知之甚少。尽管已有研究揭示了CD34在介导黏附中发挥重要作用,但其发挥促进还是抑制功能尚无定论。CD34作为一种高度糖基化的Ⅰ型跨膜蛋白,糖基化、磷酸化等翻译后修饰可能对于其构象及功能具有重要调控作用。本实验室前期工作发现了CD34共价活性位点、磷酸化修饰位点及其潜在功能。本综述结合基础研究实验结果,对CD34分子研究进展作一简要介绍和展望。 展开更多
关键词 造血干细胞 膜蛋白 翻译后修饰
下载PDF
JMJD2B和HPIP在宫颈癌组织中的表达及其与临床预后的关系
5
作者 张星 《实用癌症杂志》 2024年第6期917-920,共4页
目的分析JMJD2B与造血前B细胞白血病转录因子相互作用蛋白(HPIP)在宫颈癌组织内的表达以及与患者预后的关系。方法选取75例宫颈癌患者,术中采集其癌组织与癌旁正常组织(距肿瘤组织边缘≥3 cm)分别纳入观察组与对照组,以免疫组化法测定... 目的分析JMJD2B与造血前B细胞白血病转录因子相互作用蛋白(HPIP)在宫颈癌组织内的表达以及与患者预后的关系。方法选取75例宫颈癌患者,术中采集其癌组织与癌旁正常组织(距肿瘤组织边缘≥3 cm)分别纳入观察组与对照组,以免疫组化法测定两者的JMJD2B、HPIP表达差异。收集患者的年龄等一般资料,分析JMJD2B、HPIP表达与患者临床病理特征之间的关系。随访1年,分析JMJD2B、HPIP表达与宫颈癌患者预后的关系。结果观察组的JMJD2B、HPIP阳性表达率分别为53.33%(40/75)、45.33%(34/75),高于对照组的24.00%(18/75)、20.00%(15/75),差异均有统计学意义(P<0.05)。JMJD2B、HPIP阳性表达与宫颈癌患者的年龄、病理类型、肿瘤分期无关,与患者的肿瘤直径、分化程度、淋巴结转移、浸润程度有关(P<0.05);JMJD2B、HPIP阳性表达患者的1年生存率分别为65.00%(26/40)、55.88%(19/34),均低于阴性表达患者的85.71%(30/35)、90.24%(37/41),差异有统计学意义(P<0.05)。结论JMJD2B、HPIP在宫颈癌患者的癌组织内呈高表达,且与患者的肿瘤直径、分化程度、淋巴结转移、浸润程度有关。两者表达阳性率越高,患者生存率越低。 展开更多
关键词 宫颈癌 JMJD2B 造血前B细胞白血病转录因子相互作用蛋白 预后
下载PDF
ABNORMAL PROTEIN TYROSINE KINASES ASSOCIATED WITH HUMAN HAEMATOLOGICAL MALIGNANCIES
6
作者 孙雪梅 Graham J Lieschke 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2002年第2期79-83,共5页
Objective: To survey the role of protein tyrosine kinases (PTKs) in the pathogenesis of several hematopoietic malignancies. Methods: By reviewing the published laboratory and clinical studies on PTK-related oncoprotei... Objective: To survey the role of protein tyrosine kinases (PTKs) in the pathogenesis of several hematopoietic malignancies. Methods: By reviewing the published laboratory and clinical studies on PTK-related oncoproteins and their causative role in some leukemias and lymphomas. Results: Protein tyrosine kinases are key participants in signal transduction pathways that regulate cellular growth, activation and differentiations. Aberrant PTK activity resulting from gene mutation (often accompanying chromosome translocation) plays an etiologic role in several clonal hematopoietic malignancies. For example, the PTK product of the BCR-ABL fusion gene resulting from the t (9; 22) translocation exhibits several fold higher tyrosine kinase activity than the product of the ABL gene. Evidence suggests that the BCR-ABL oncoprotein alone is sufficient to case chronic myelogenous leukemia (CML) and other Ph positive acute leukemia. PTK over-activity resulting from chromosomal translocations creating TEL-ABL, TEL-JAK2 and TEL-PDGFRβ fusion proteins plays an important role in the pathogenesis of other types of leukemia. Another example occurs in anaplastic large cell lymphoma (ALCL). Experimental and clinical evidences indicate that translocations involving ALK gene on chromosome 2p23, most commonly resulting in an NPM-ALK fusion oncogene, result in constitutive activation of ALK and cause ALCL. This group of lymphomas is now named ALK positive lymphoma or ALKoma. Conclusion: Genetic lesions creating aberrant fusion proteins that result in excessive PTK activity are increasingly being recognized as central to the pathogenesis of hemotopoietic malignancies. These chimeric PTK molecules represent attractive disease-specific targets against which new classes therapeutic agents are being developed. 展开更多
关键词 protein tyrosine kinase (PTK) hematopoietic malignancy BCR-ABL Chronic myelogenous leukemia (CML) Anaplastic large cell lymphoma (ALCL) STI 571 protein tyrosine kinase inhibitor
下载PDF
Prokaryotic Expression of Glycoprotein Gene of Infectious Hnematopoietic Necrosis Virus and Polyclonal Antibody Preparation
7
作者 Liu Xueguang Zheng Huaidong +3 位作者 Guo Xinshuo Luo Jin Lin Cuicui Wang Qiuyu 《Animal Husbandry and Feed Science》 CAS 2014年第2期55-58,共4页
[Objective]The aim is to perform prokaryotic expression of the glycoprotein gene of infectious hnematopoietic necrosis virus and polyclonal antibody preparation. [Methods]Glycoprotein gene( G) of infectious hematopoie... [Objective]The aim is to perform prokaryotic expression of the glycoprotein gene of infectious hnematopoietic necrosis virus and polyclonal antibody preparation. [Methods]Glycoprotein gene( G) of infectious hematopoietic tissue( IHNV) was synthesized,cloned to prokaryotic expression system pET-30a vector,yielding the recombinant plasmid pET-30a-IHNV-G. The yielded pET-30a-IHNV-G was transformed into E. coli strain BL21( DE3) plySs. [Results] SDSPAGE and Western blot results showed that protein G successfully expressed in E. coli at 37 ℃,1 mmol /L IPTG induction for 4 h. The molecular weight of fusion G protein was 57 KD. The polyclonal antibody was prepared by immunizing mice with the product of gel purification. ELISA analysis showed that the serum titer reached 1∶10 000. [Conclusion]The expressed G protein and the serum with polyclonal antibody obtained in this study provided the theoretical basis for the development of IHNV vaccine and detection of colloidal gold test strip. 展开更多
关键词 Infectious hematopoietic necrosis virus(IHNV) Prokaryotic expression Inclusion body G protein ANTIBODY
下载PDF
HAX-1调控人宫颈癌Hela的细胞增殖
8
作者 季瑞 唐敏 +3 位作者 徐海波 姚涓 陆云燕 金华 《临床检验杂志》 CAS 2023年第5期374-379,共6页
目的探讨造血细胞特异性蛋白1(HS-1)相关蛋白X-1(HAX-1)对宫颈癌Hela细胞增殖的调控作用。方法以人宫颈癌Hela细胞系为研究模型,采用脂质体介导法将HAX-1 siRNAs和阴性对照siRNA转染Hela细胞并构建HAX-1沉默细胞系(HAX-1沉默组),以HAX-... 目的探讨造血细胞特异性蛋白1(HS-1)相关蛋白X-1(HAX-1)对宫颈癌Hela细胞增殖的调控作用。方法以人宫颈癌Hela细胞系为研究模型,采用脂质体介导法将HAX-1 siRNAs和阴性对照siRNA转染Hela细胞并构建HAX-1沉默细胞系(HAX-1沉默组),以HAX-1高表达质粒和pcDNA3.1空载质粒转染Hela细胞并构建HAX-1过表达细胞系(HAX-1过表达组)。采用实时荧光定量PCR(RT-qPCR)和Western blot检测转染后Hela细胞中HAX-1的表达情况;EdU试验检测转染后的细胞增殖能力;MTT试验检测转染后的细胞活力;流式细胞术检测HAX-1对转染后Hela细胞周期和细胞凋亡的变化;RT-qPCR检测转染后Ki-67、c-Myc、BCL-2/BAX基因的表达水平。结果沉默HAX-1后,Hela细胞中HAX-1 mRNA和蛋白质的水平显著降低,而过表达HAX-1后,Hela细胞中HAX-1 mRNA和蛋白质的水平显著升高,差异均有统计学意义(P<0.05)。过表达HAX-1后,HAX-1过表达组中EdU阳性细胞数目下降,细胞活力降低,G1期细胞比例增加,S期细胞比例降低,细胞凋亡率上升,增殖相关基因Ki67表达降低,BCL-2/BAX基因显著降低(P<0.05),而HAX-1沉默组则具有相反的表现。结论HAX-1的表达抑制了Hela细胞增殖,并通过BCL-2/BAX途径诱导其凋亡。 展开更多
关键词 造血细胞特异性蛋白1相关蛋白X-1 宫颈腺癌 凋亡 细胞增殖
下载PDF
SLAMF6、BCL-2/Bax对重型再生障碍性贫血患者HSCT疗效的预测价值分析
9
作者 刘晓燕 刘文超 尹婷婷 《国际检验医学杂志》 CAS 2023年第3期273-279,共7页
目的探讨信号淋巴细胞激活分子家族6(SLAMF6)、B淋巴细胞瘤-2基因(BCL-2)蛋白/Bcl-2相关X蛋白(BCL-2/Bax)对重型再生障碍性贫血(SAA)患者造血干细胞移植(HSCT)疗效的预测价值。方法将2017年3月至2020年10月于该院接受HSCT治疗的56例SAA... 目的探讨信号淋巴细胞激活分子家族6(SLAMF6)、B淋巴细胞瘤-2基因(BCL-2)蛋白/Bcl-2相关X蛋白(BCL-2/Bax)对重型再生障碍性贫血(SAA)患者造血干细胞移植(HSCT)疗效的预测价值。方法将2017年3月至2020年10月于该院接受HSCT治疗的56例SAA患者纳入研究。HSCT治疗后随访1年,评价治疗效果,比较不同治疗效果患者外周血CD8^(+)T淋巴细胞SLAMF6的表达量、BCL-2/Bax水平。分析外周血CD8^(+)T淋巴细胞SLAMF6表达量、BCL-2/Bax水平与中性粒细胞植活时间、血小板植活时间的相关性,采用多元线性回归分析中性粒细胞植活时间、血小板植活时间的影响因素,并建立回归方程。结果SAA患者经HSCT治疗后,以中性粒细胞植活时间、血小板植活时间均值为界,高于均值的患者移植物抗宿主病、感染并发症发生率更低(P<0.05);外周血CD8^(+)T淋巴细胞SLAMF6表达量、BCL-2/Bax水平与中性粒细胞植活时间、血小板植活时间均呈负相关(r<0,P<0.05);经多元线性回归分析,筛选出与中性粒细胞植活时间、血小板植活时间有线性关系的因素,外周血CD8^(+)T淋巴细胞SLAMF6表达量、BCL-2/Bax水平对应的线性系数差异有统计学意义(P<0.05);建立中性粒细胞植活时间回归模型:中性粒细胞植活时间=35.807-0.325×SLAMF6-1.255×BCL-2/Bax(R^(2)=0.894),血小板植活时间=67.220-2.999×SLAMF6-19.704×BCL-2/Bax(R^(2)=0.927),回归模型均有统计学意义(P<0.05)。结论外周血CD8^(+)T淋巴细胞SLAMF6表达量、BCL-2/Bax与SAA患者HSCT治疗后中性粒细胞植活时间、血小板植活时间密切相关,可用于HSCT的疗效预测。 展开更多
关键词 信号淋巴细胞激活分子家族6 B淋巴细胞瘤-2基因 重型再生障碍性贫血 造血干细胞移植
下载PDF
HAX-1通过调控MDM2/SMAD3通路对TGF-β1诱导的特发性肺间质纤维化的作用机制 被引量:1
10
作者 高崴崴 刘待见 +2 位作者 张晓萍 冯青青 刘颖 《河南医学研究》 CAS 2023年第12期2113-2118,共6页
目的探讨造血细胞特异性蛋白1相关蛋白X-1(HAX-1)对转化生长因子-β1(TGF-β1)诱导的特发性肺间质纤维化的作用及机制。方法将A549细胞分为对照组(无处理)、TGF-β1组(用5μg·L^(-1)的TGF-β1诱导48 h)、NC si组(用阴性对照siRNA... 目的探讨造血细胞特异性蛋白1相关蛋白X-1(HAX-1)对转化生长因子-β1(TGF-β1)诱导的特发性肺间质纤维化的作用及机制。方法将A549细胞分为对照组(无处理)、TGF-β1组(用5μg·L^(-1)的TGF-β1诱导48 h)、NC si组(用阴性对照siRNA转染细胞,再用5μg·L^(-1)的TGF-β1诱导48 h)、HAX-1 si组(用HAX-1 siRNA转染细胞,再用5μg·L^(-1)的TGF-β1诱导48 h)、HAX-1 si+pcDNA3.1组(用HAX-1 siRNA转染细胞,再用pcDNA3.1空质粒转染细胞,再用5μg·L^(-1)的TGF-β1诱导48 h)、HAX-1 si+MDM2组(用HAX-1 siRNA转染细胞,再用MDM2过表达质粒pcDNA3.1-MDM2转染细胞,再用5μg·L^(-1)的TGF-β1诱导48 h)、HAX-1 si+MDM2+DMSO组(用HAX-1 siRNA转染细胞,再用MDM2过表达质粒pcDNA3.1-MDM2转染细胞,向细胞培养液中加入溶剂DMSO处理细胞30 min,再用5μg·L^(-1)的TGF-β1诱导48 h)、HAX-1 si+MDM2+SIS3组(用HAX-1 siRNA转染细胞,再用MDM2过表达质粒pcDNA3.1-MDM2转染细胞,用终浓度为1μmol·L^(-1)溶于DMSO的SIS3处理细胞30 min,再用5μg·L^(-1)的TGF-β1诱导48 h)。相应处理结束后,采用倒置相差显微镜观察细胞形态变化;Western blot检测HAX-1、鼠双微体基因2(MDM2)、SMAD3、p-SMAD3、E-钙黏蛋白(E-cadherin)、α-平滑肌肌动蛋白(α-SMA)和Ⅰ型胶原α1链(COL1A1)蛋白表达水平。结果TGF-β1诱导细胞后,细胞由鹅卵石形或多角形转变为梭形、纺锤形,E-cadherin蛋白表达降低(P<0.05),HAX-1、α-SMA和COL1A1蛋白表达升高(P<0.05)。干扰HAX-1可提高E-cadherin蛋白表达(P<0.05),抑制MDM2、p-SMAD3、α-SMA和COL1A1蛋白表达(P<0.05),并且细胞形态又转变为鹅卵石形或多角形。MDM2过表达抵消HAX-1干扰对p-SMAD3、E-cadherin、α-SMA和COL1A1蛋白表达的影响(P<0.05)。SMAD3抑制剂SIS3处理后细胞形态又转变为鹅卵石形或多角形,E-cadherin蛋白表达升高(P<0.05),α-SMA和COL1A1蛋白表达下降(P<0.05)。结论HAX-1在TGF-β1诱导的A549细胞中高表达,HAX-1敲低可通过MDM2/SMAD3通路抑制TGF-β1诱导的肺泡细胞纤维化过程。 展开更多
关键词 特发性肺间质纤维化 造血细胞特异性蛋白1相关蛋白X-1 转化生长因子β1 鼠双微体基因2 SMAD3
下载PDF
GATA结合蛋白1的造血调控功能及其突变导致的红系/巨核系相关遗传病 被引量:2
11
作者 丁碧莹 王学锋 《中国输血杂志》 CAS 2023年第1期85-90,共6页
GATA结合蛋白1(GATA1)是1个重要的造血谱系转录因子,在转录水平上特异性调控红系和巨核系细胞的增殖和分化,以此维持这2个系细胞的正常发育成熟。GATA1的功能结构由1个N端转录激活域(N-TAD)和2个锌指结构(NF与CF)构成。GATA1的蛋白序列... GATA结合蛋白1(GATA1)是1个重要的造血谱系转录因子,在转录水平上特异性调控红系和巨核系细胞的增殖和分化,以此维持这2个系细胞的正常发育成熟。GATA1的功能结构由1个N端转录激活域(N-TAD)和2个锌指结构(NF与CF)构成。GATA1的蛋白序列在不同物种中高度保守,其改变将导致红系和巨核系相关基因转录失调,从而产生程度不一的临床表型。本文从GATA1的分子结构、在红系和巨核系细胞中的造血调控功能以及突变导致的遗传性红系/巨核系造血调控紊乱等方面予以综述。 展开更多
关键词 GATA结合蛋白1 红细胞系 巨核细胞系 造血调控紊乱 转录调控 锌指结构 基因突变
下载PDF
Panax Notoginseng Saponins Induced Up-Regulation,Phosphorylation and Binding Activity of MEK,ERK,AKT,PI-3K Protein Kinases and GATA Transcription Factors in Hematopoietic Cells 被引量:11
12
作者 孙馨 高瑞兰 +2 位作者 林筱洁 徐卫红 陈小红 《Chinese Journal of Integrative Medicine》 SCIE CAS 2013年第2期112-118,共7页
Objective: To investigate the effects of panax notoginseng saponins (PNS) on expression, regulation and phosphorylation of multiple protein kinases in mitogen activated protein kinase (MAPK) intracellular signal ... Objective: To investigate the effects of panax notoginseng saponins (PNS) on expression, regulation and phosphorylation of multiple protein kinases in mitogen activated protein kinase (MAPK) intracellular signal pathway and GATA transcription factors in hematopoietic cells, so as to explore its mechanism of proliferation and differentiation activity on hematopoiesis. Methods: The human granulocytic HL-60, erythrocytic K562, megakaryocytic CHRF-288 and Meg-01 cell lines were treated by PNS, the positive control of K562, CHRF-288 ceils treated by recombination human erythropoietin (Epo) and thrombopoietin (Tpo) respectively. The total cell lysate and nuclei protein were extracted after being treated by PNS, subsequently, analyzed by both Western blot and immune-precipitation. Meanwhile, the nuclei extract was performed for electrophoretic mobility shift assay (EMSA) by using 32p radio labeled double-stranded GATA consensus oligonucleotide. Results: The expression levels of kinase MEK-1, MEK-2, ERK-1, ERK-2, AKT-1, AKT-2 and PI- 3K were increased by PNS treatment to different extent in four cell lines, depending on cellular heterogeneity and sensitivity to PNS, also phosphorylation of MEK-1, ERK-1 was differentially promoted by PNS respectively (P〈0.05, 0.01, 0.001). The expression levels of transcription factors GATA-1 and GATA-2 were increased, moreover, their DNA binding activities were raised dramatically in PNS treated K562, CHRF-288 and Meg-01 cells compared with the controls respectively (P〈0.05, 0.01, 0.001). The positive control of K562, CHRF-288 cells treated by Epo or Tpo respectively also displayed up-regulation of protein kinases and GATA transcription factors respectively (P〈0.05, 0.01, 0.001). Conclusion: The results indicated that intracellular signal pathway initiated by PNS was involved in MAPK pathway and transcription factors of GATA family in hematopoietic cells. PNS displayed the role to promote proliferation and differentiation, by means of increasing expression level and phosphorylation status of multiple protein kinases, also inducing synthesis of GATA transcription factors and up- regulation its DNA binding activity. 展开更多
关键词 panax notoginseng saponins hematopoietic cells protein kinase PHOSPHORYLATION transcription factor
原文传递
宫颈癌组织含Jumonji结构域的蛋白2B、造血相关PBX相互作用蛋白的表达与预后关系的分析
13
作者 苗晓红 袁志英 +2 位作者 李媛 韩秀青 李光 《中国性科学》 2023年第1期60-65,共6页
目的 探讨宫颈癌(CC)组织中含Jumonji结构域的蛋白2B(JMJD2B)、造血相关PBX相互作用蛋白(HPIP)的表达与患者预后的关系。方法 选取2014年6月至2016年6月唐山市妇幼保健院收治的84例CC患者作为研究对象。采用免疫组织化学法检测CC组织中J... 目的 探讨宫颈癌(CC)组织中含Jumonji结构域的蛋白2B(JMJD2B)、造血相关PBX相互作用蛋白(HPIP)的表达与患者预后的关系。方法 选取2014年6月至2016年6月唐山市妇幼保健院收治的84例CC患者作为研究对象。采用免疫组织化学法检测CC组织中JMJD2B、HPIP蛋白表达情况,分析JMJD2B、HPIP蛋白表达与临床病理特征的关系。采用定量聚合酶链反应(PCR)法检测CC组织中JMJD2B、HPIP mRNA表达水平,分析各相关因素与CC患者5年总存活率(OS)的关系。结果 84例CC组织样本中,JMJD2B、HPIP蛋白阳性表达率分别为60.71%和54.76%;不同病理类型、国际妇产科联盟(FIGO)分期、有无淋巴节转移及不同分化程度CC组织中JMJD2B、HPIP蛋白阳性表达率均存在显著差异(P<0.05)。CC组织中JMJD2B、HPIP mRNA表达水平均显著高于CC癌旁组织(P<0.05);FIGO分期高、有淋巴节转移、分化程度低及JMJD2B、HPIP阳性表达均是CC患者5年OS的独立危险因素(P<0.05)。结论 CC组织中JMJD2B、HPIP表达均显著上调,且均是CC患者的独立预后指标。 展开更多
关键词 宫颈癌 含Jumonji结构域的蛋白2B 造血相关PBX相互作用蛋白 预后 免疫组织化学法
下载PDF
Inducing effects of macrophage stimulating protein on the expansion of early hematopoietic progenitor cells in liquid culture 被引量:2
14
作者 MA Li-xia HUANG Yan-hong +2 位作者 CHENG La-mei LEI Jun WANG Qi-ru 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第13期1192-1197,共6页
Background Macrophage stimulating protein (MSP) is produced by human bone marrow endothelial cells. In this study we sought to observe its effects on inducing the expansion of early hematopoietic progenitor cells wh... Background Macrophage stimulating protein (MSP) is produced by human bone marrow endothelial cells. In this study we sought to observe its effects on inducing the expansion of early hematopoietic progenitor cells which were cultured in a liquid culture system in the presence of the combination of stem cell factor (SCF), interleukin 3 (IL-3), interleukin 6 (IL-6), granulocyte macrophage-colony stimulating factor (GM-CSF), erythropoietin (EPO) (Cys) and MSP or of Cys and bone marrow endothelial cell conditioned medium (EC-CM). Methods Human bone marrow CD34^+ cells were separated and cultured in a liquid culture system for 6 days. Granulocyte-macrophage colony forming unit (CFU-GM) and colony forming unit-granulocyte, erythrocyte, macrophage, megakaryocyte (CFU-GEMM) were employed to assay the effects of different treatment on the proliferation of hematopoeitic stem/progenitor cells. The nitroblue tetrazolium (NBT) reductive test and hoechest 33258 staining were employed to reflect the differentiation and apoptosis of the cells respectively. Results MSP inhibited the proliferation of CFU-GM and CFU-GEMM in semi-solid culture and the inhibitory effect on CFU-GEMM was stronger than on CFU-GM. MSP inhibited the differentiation of early hematopoietic progenitor cells induced by hematopoietic stimulators. Bone marrow (BM) CFU-GEMM was 2.3-fold or 1.7-fold increase or significantly decreased in either Cys+EC-CM, Cys+MSP or Cys compared with 0 hour control in liquid culture system after 6 days. Conclusion MSP, a hematopoietic inhibitor, inhibits the differentiation of early hematopoietic progenitor cells induced by hematopoietic stimulators and makes the early hematopoietic progenitor cells expand in a liquid culture system. 展开更多
关键词 macrophage stimulating protein bone marrow endothelial cell hematopoietic progenitor cells
原文传递
Dynamic roles of angiopoietin-like proteins 1, 2, 3, 4, 6 and 7 in the survival and enhancement of ex vivo expansion of bone-marrow hematopoietic stem cells 被引量:3
15
作者 Shahina Akhter MdMashiar Rahman +2 位作者 Hyun Seo Lee Hyeon-Jin Kim Seong-Tshool Hong 《Protein & Cell》 SCIE CSCD 2013年第3期220-230,共11页
Recent advances in hematopoietic stem cells(HSCs)expansion by growth factors including angiopoietin-like proteins(Angptls)have opened up the possibility to use HSCs in regenerative medicine.However,the unavailability ... Recent advances in hematopoietic stem cells(HSCs)expansion by growth factors including angiopoietin-like proteins(Angptls)have opened up the possibility to use HSCs in regenerative medicine.However,the unavailability of true in vitro HSCs expansion by these growth factors has limited the understanding of the cellular and molecular mechanism of HSCs expansion.Here,we report the functional role of mouse Angptls 1,2,3,4,6 and 7 and growth factors SCF,TPO,IGF-2 and FGF-1 on purified mouse bone-marrow(BM)Lineage-Sca-1+(Lin-Sca-1+)HSCs.The recombinant retroviral transduced-CHO-S cells that secrete Angptls in serum-free medium were used alone or in combination with growth factors(SCF,TPO,IGF-2 and FGF-1).None of the Angptls stimu-lated HSC proliferation,enhanced or inhibited HSCs colony formation,but they did support the survival of HSCs.By contrast,any of the six Angptls together with saturating levels of growth factors dramatically stimulated a 3-to 4.5-fold net expansion of HSCs compared to stimulation with a combination of those growth factors alone.These findings lead to an understanding of the basic function of Angptls on signaling pathways for the survival as well as expansion of HSCs in the bone marrow niche. 展开更多
关键词 hematopoietic stem cells angiopoietin-like proteins growth factors SURVIVAL ex vivo expansion cell culture
原文传递
Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation 被引量:1
16
作者 WANG Zhi-dong LI Dan HUANG Xiao-jun 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第7期912-916,共5页
Background The role of Wilms' tumor 1 protein (WT1)-specific cytotoxic T cells (CTL) in eradicating chronic myeloid leukemia (CML) cells is to be established. The aim of this study was to determine whether WT1 ... Background The role of Wilms' tumor 1 protein (WT1)-specific cytotoxic T cells (CTL) in eradicating chronic myeloid leukemia (CML) cells is to be established. The aim of this study was to determine whether WT1 contributed to the graft-versus-leukemia effects (GVLE) for CML following allogeneic hematopoietic stem cell transplantation (HSCT). Methods High-resolution human leukocyte antigen (HLA) class I genotyping was performed by sequence-specific polymerase chain reaction (PCR). Fifteen HLA-A~*2402 patients with CML who underwent allogeneic HSCT were enrolled in this study. We monitored the frequency of WT1-specific CTL by pentamer assay and the molecular minimal residual disease by real-time quantitative PCR.Results A CD8+ T-cell response to WT1 was observed in 14 of 15 patients after HSCT. The median frequencies of WT1-CTL were 0.54%, 0.62%, 0.81% and 1.28% (%CD8) on days 30, 60, 90 and 180, respectively. The median frequency of WT1-CTL (1.38%) in patients with molecular remission (MoR) was significantly higher than that in those without MoR (0.38%) on day 30, while no significant differences between them were detected on days 60, 90 and 180. The increase of WT1-CTL was associated with a decrease in bcr-abl expression and MoR; and the decrease of WT1-CTL was associated with an increase in bcr-abl expression, suggesting a WT1 -driven GVL effect. WT1-CTL had a predominant effector-memory phenotype (CD45RO+CD27-CD57+).Conclusions The emergence of WT1-CTL with an effector-memory phenotype is associated with GVLE in CML patients after HSCT. This will pave the way for the WT1 vaccines to enhance GVLE after HSCT in CML. 展开更多
关键词 cytotoxic T cells Wilms' tumor 1 protein graft-versus-leukemia effects chronic myeloid leukemia allogeneic hematopoietic stem cell transplantation
原文传递
鱼类传染性造血器官坏死病病毒糖蛋白的截短表达及免疫原性检测 被引量:5
17
作者 赵景壮 徐黎明 +4 位作者 刘淼 曹永生 尹家胜 刘红柏 卢彤岩 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第12期1238-1242,共5页
目的研究鱼类传染性造血器官坏死病病毒(IHNV)糖蛋白不同区域对免疫原性的影响。方法本研究通过DNAStar 6.0软件分析糖蛋白跨膜区、疏水性及抗原性后,对其进行截短表达;纯化后的糖蛋白制备兔抗血清,ELISA检测兔抗血清的效价,用间接免疫... 目的研究鱼类传染性造血器官坏死病病毒(IHNV)糖蛋白不同区域对免疫原性的影响。方法本研究通过DNAStar 6.0软件分析糖蛋白跨膜区、疏水性及抗原性后,对其进行截短表达;纯化后的糖蛋白制备兔抗血清,ELISA检测兔抗血清的效价,用间接免疫荧光技术检测纯化后蛋白的免疫原性。结果 SDS-PAGE结果显示,截短糖蛋白相对分子质量(Mr)为40 000,纯化后的糖蛋白经高效液相色谱检测纯度达到90%。利用纯化后的蛋白制备兔抗血清,ELISA结果显示,所制备的兔抗血清与糖蛋白的反应效价为1∶80 000,与IHNV-Sn株细胞培养物的反应效价为1∶20 000;间接免疫荧光结果显示,兔抗血清与IHNV-Sn分离株及参考毒株均能发生特异性的反应。结论实验所表达的糖蛋白与天然的病毒表面糖蛋白具有几乎相同的免疫原性。 展开更多
关键词 传染性造血器官坏死病毒 蛋白表达 糖蛋白 免疫原性
下载PDF
恶性血液病造血干细胞移植后感染病原菌分布及对BCL-2、BAX蛋白表达的影响 被引量:5
18
作者 苏贵平 戴艳 +4 位作者 黄来全 蒋艺枝 耿良权 丁凯阳 黄东平 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第3期840-844,共5页
目的:探讨恶性血液病患者外周血造血干细胞移植术后感染病原菌分布及对BCL-2、BAX蛋白表达的影响。方法:对2011年1月-2015年12月在弋矶山医院及省立医院血液科行造血干细胞移植的64例恶性血液病患者的临床资料进行分析,按照术后是否感... 目的:探讨恶性血液病患者外周血造血干细胞移植术后感染病原菌分布及对BCL-2、BAX蛋白表达的影响。方法:对2011年1月-2015年12月在弋矶山医院及省立医院血液科行造血干细胞移植的64例恶性血液病患者的临床资料进行分析,按照术后是否感染分为感染组(36例)和非感染组(28例),对造血干细胞移植后感染病原菌进行菌型鉴定,并对两组患者外周血T淋巴细胞亚群、C-反应蛋白(C-reaction protein,CRP)水平及血清细胞凋亡蛋白表达进行测定。结果:36例恶性血液病患者经造血干细胞移植后,从感染患者分离出病原菌共36株,其中革兰阴性菌24株(66.67%)且以肺炎克雷伯杆菌(19.44%)为主,感染组患者外周血中CD4+水平(t=2.637,P<0.01)、CD4+/CD8+比值(t=8.223,P<0.01)、BCL-2蛋白表达(t=5.852,P<0.01)、BCL-2/BAX比值(t=14.56,P<0.01)均显著低于非感染组,而感染组CD8+表达(t=2.285,P<0.01)、CRP水平(t=39.71,P<0.01)和BAX蛋白表达水平均高于非感染组。Pearson相关性检验分析发现,感染组患者CD4+/CD8+比值与BCL-2/BAX比值呈正相关(r=0.341,P<0.05),血清CRP水平与BCL-2/BAX比值呈负相关(r=-0.362,P<0.05)。结论:恶性血液病患者外周血造血干细胞移植术后感染病原菌以革兰阴性菌为主,术后感染能够促进相关炎症因子和凋亡蛋白表达的上调,病原菌可能也参与细胞凋亡过程。 展开更多
关键词 恶性血液病 造血干细胞移植 感染 细胞凋亡蛋白
下载PDF
当归多糖对小鼠骨骼肌卫星细胞增殖及干细胞因子受体蛋白表达的影响 被引量:14
19
作者 王晓玲 汪涛 +1 位作者 汪雅妮 王学谦 《中国中西医结合杂志》 CAS CSCD 北大核心 2012年第1期93-96,共4页
目的观察在体外造血微环境中,当归多糖(angelica polysaccharides,APS)对不同培养条件下乳鼠骨骼肌卫星细胞(muscle satellite cells,MSCs)增殖及干细胞因子受体蛋白(c-kit)表达的影响。方法原代培养MSC,5天后采用结蛋白(desmin)免疫细... 目的观察在体外造血微环境中,当归多糖(angelica polysaccharides,APS)对不同培养条件下乳鼠骨骼肌卫星细胞(muscle satellite cells,MSCs)增殖及干细胞因子受体蛋白(c-kit)表达的影响。方法原代培养MSC,5天后采用结蛋白(desmin)免疫细胞化学鉴定;细胞随机分为8组,即空白对照组,骨髓基质细胞培养上清组,加入含100、200、300μg/mLAPS的DMEM/F12培养基实验组及经100、200、300μg/mLAPS干预后骨髓基质细胞条件培养基组,采用MTT法检测各组细胞的增殖活性及对细胞进行c-kit免疫细胞化学染色。结果分离培养的MSCs呈desmin染色阳性;MTT法检测发现各条件培养基实验组MSCs增殖显著;c-kit免疫强阳性反应存在于条件培养基培养的各组MSCs中,c-kit主要表达于细胞质。结论经APS干预的骨髓基质细胞条件培养基可以有效改变MSCs的生长特性,明显促进MSCs增殖及c-kit的表达,c-kit在MSCs增殖过程中可能起某种调节作用。 展开更多
关键词 肌卫星细胞 当归多糖 造血微环境 增殖 干细胞因子受体蛋白
下载PDF
移植日C反应蛋白水平对异基因造血干细胞移植早期感染及预后的预测意义 被引量:4
20
作者 沈克锋 刘启发 +14 位作者 孙竞 江千里 张钰 周红升 戴敏 肖敏 王瑾 罗莉 李钦璐 安海云 洪振亚 孟力 杨默 周剑峰 王高翔 《南方医科大学学报》 CAS CSCD 北大核心 2015年第11期1535-1539,共5页
目的探讨移植日C反应蛋白(CRP)水平对异基因造血干细胞移植早期败血症等感染事件发生的预测意义。方法回顾性分析78例异基因移植患者病例资料,采用受试者工作特征曲线(ROC)评估CRP诊断移植早期败血症的临床参考值及相应灵敏度和特异... 目的探讨移植日C反应蛋白(CRP)水平对异基因造血干细胞移植早期败血症等感染事件发生的预测意义。方法回顾性分析78例异基因移植患者病例资料,采用受试者工作特征曲线(ROC)评估CRP诊断移植早期败血症的临床参考值及相应灵敏度和特异度,以所得临床参考值为临界值将病例资料分为低CRP组和高CRP组,分析比较两组间的移植相关并发症及总生存(OS)和复发率等。结果 CRP诊断移植早期败血症的临床参考值为23.3 mg/L(AUC=0.735,P=0.001,95%CI0.623~0.848),相应灵敏度和特异度分别为0.793和0.592;高CRP组粒系平均重建时间较低CRP组延迟0.71 d(P=0.237),巨核系平均重建时间显著延迟4.09 d(P=0.048);高CRP组移植早期败血症及巨细胞病毒(CMV)血症发生率较低CRP组显著增高(53.5%vs 17.1%,P=0.001;72.1%vs 37.1%,P=0.003),但两组间EB病毒(EBV)血症、肺部侵袭性真菌感染及急性移植物抗宿主病(a GVHD)发生率无统计学差异(41.9%vs 22.9%,P=0.094;14.0%vs 5.7%,P=0.285,51.2%vs 45.7,P=0.656);高CRP组中位随访318(7~773)d,低CRP组中位随访299(78~747)d,高CRP组2年OS率较低CRP组显著降低(42.5%vs78.4%,P=0.022),高CRP组2年累计复发率较低CRP组高(52.3%vs 19.8%,P=0.235),但差异无统计学意义;Logistic多因素分析显示高CRP水平是移植早期败血症的独立危险因素(OR=5.090,95%CI 1.115~23.229,P=0.036)。结论移植日CRP水平对异基因造血干细胞移植早期败血症有一定的预测意义,高CRP水平提示较高的移植早期败血症和CMV血症发生率以及较差的预后。 展开更多
关键词 C反应蛋白 异基因造血干细胞移植 败血症 预后
下载PDF
上一页 1 2 7 下一页 到第
使用帮助 返回顶部